Rapid progress has been made in recent years in our understanding of the mechanisms
regulating the formation, activation, and survival of osteoclasts, which are derived from …

Osteoclast precursors: cytokine-stimulated immunomodulators... : Current Opinion in
Rheumatology Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory …

Human osteoclast formation from monocyte precursors under the action of receptor activator
of nuclear factor-κB ligand (RANKL) was suppressed by granulocyte macrophage colony …

Abstract Objective. Histone deacetylase 1 (HDAC1) is highly expressed in the synovium of
RA patients. Thus we aimed to investigate a novel HDAC inhibitor (HDACi), NW-21 …

Histone deacetylase inhibitors (HDACi) suppress cancer cell growth, inflammation, and
bone resorption. The aim of this study was to determine the effect of inhibitors of different …

Chemokines MCP‐1 and RANTES are induced when authentic bone resorbing human
osteoclasts differentiate from monocyte precursors in vitro. In addition, MCP‐1 and RANTES …

Sperm sexing through flow-sorting technology is relatively expensive, requires considerable
technical support and is actually not practicable in many developing countries. The aim of …

The regulation of epigenetic factors is an emerging therapeutic target of immune function in
a variety of osteolytic pathologies. Histone deacetylases (HDAC) modify core histone …

Human osteoclasts were differentiated using receptor activator of NFκB ligand (RANKL) and
macrophage colony stimulating factor (M‐CSF) from colony forming unit‐granulocyte …

Azithromycin is an antibiotic with anti‐inflammatory properties used as an adjunct to treat
periodontitis, a common inflammatory mediated condition featuring pathologic alveolar bone …